People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Other, Biotechnology, Robotics
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ara Divert HoldCo, Inc. | — | Other | Series C | $80.0M | $807.4M | 2023 |
| Eterna Therapeutics Inc. | — | Biotechnology | Series A | $53.1M | $26.5M | 2022 |
| Square Robot, Inc. | — | Robotics | Series A | $39.0M | $22.6M | 2022 |
Charles Cherington at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Cherington on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Angel | 1 | 5 |
| Edward Sullivan | 1 | 5 |
| Andrew Jackson | 1 | 4 |
| Gregory Fiore | 1 | 3 |
| Cory Steffek | 1 | 3 |
| Richard W. Wagner | 1 | 3 |
| Jeff Berg | 1 | 2 |
| Kendra Berger | 1 | 2 |
| STEVE MITGANG | 1 | 2 |
| David Lamont | 1 | 2 |
| Ari David | 1 | 2 |
| Erin S. Enright | 1 | 2 |
| James Bristol | 1 | 2 |
| David Therrien | 1 | 2 |
| Heather B. Redman | 1 | 2 |
| Ryan Begin | 1 | 2 |
| TONY UPHOFF | 1 | 1 |
| PAUL YANOVER | 1 | 1 |
| Joseph J. Farricielli, Jr. | 1 | 1 |
| KIRK NAGAMINE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.